首页> 外文会议>Conference on ophthalmic technologies XXVII >Characterization of the lamellar rearrangement induced by cross-linking treatment in keratoconic corneal samples imaged by SHG microscopy
【24h】

Characterization of the lamellar rearrangement induced by cross-linking treatment in keratoconic corneal samples imaged by SHG microscopy

机译:通过SHG显微镜成像的角振来角膜样品交联治疗诱导的层状重排的表征

获取原文
获取外文期刊封面目录资料

摘要

Keratoconus is an eye disorder that features a reduced stiffness of the cornea and its consequent pathological deformation. Cross-Linking (CXL) treatment has proven useful in hindering the progression of keratoconus, offering a minimally-invasive alternative to corneal surgical transplantation. In this study, the biomechanical characteristics of a human keratoconic cornea were clinically examined in vivo soon before keratoplasty, and the morphological alterations of the collagen scaffold in the same cornea were examined ex vivo by means of Second-Harmonic Generation (SHG) microscopy. A healthy cornea and a CXL-treated keratoconus were compared. In particular, the lamellar organization in the three corneal samples was characterized in different stromal layers by detecting both forward- and backward-scattered SHG signal and then considering the forward/backward (F/B) ratio as parameter. The F/B ratio was used to characterize the morphological organization of collagen lamellae within different stromal layers, finding an increased disorder at the level of Bowman's membrane, opposed to a more regular organization within deeper stromal layers in all the examined samples. The organization of collagen lamellae in CXL-treated keratoconic samples was similar to that one found in healthy corneas, demonstrating that the CXL is able to rearrange the collagen scaffold and partially recover the properties of a healthy condition. The obtained results are in agreement with previous results obtained in studies aimed at monitoring the organization of fibrillar collagen using F/B SHG ratio. In conclusion, the proposed method might be useful for both diagnosing keratoconus as well as for monitoring the effects of the CXL treatment.
机译:角蛋白是一种眼部疾病,其特征在于角膜的刚度,其随之而来的病理变形。交联(CXL)治疗已被证明是有助于阻碍角蛋白的进展,为角膜外移植提供了一种微创替代品。在这项研究中,在角膜术前很快在体内体内检查人角振蚀变角膜的生物力学特征,并通过二次谐波产生(SHG)显微镜检查相同角膜中的胶原蛋白支架的形态学改变。比较了健康的角膜和CXL处理的角蛋白酶。特别地,三个角膜样品中的层状组织在不同的基质层中,通过检测向后散射的SHG信号,然后将正向/向后(F / B)比视为参数。 F / B比用于表征不同的基质层内胶原膜的形态组织,在鲍曼膜的水平上发现增加的疾病,而不是在所有检查样本中更深的基质层内的常规组织。 CXL处理的角抗圆形样品中的胶原蛋白薄膜组织类似于健康角膜中发现的那个,证明CXL能够重新排列胶原蛋白支架并部分地回收健康状况的性质。获得的结果符合在研究中获得的先前结果,旨在使用F / B SHG比率监测纤维结合胶原蛋白组织。总之,所提出的方法可能对诊断角蛋白酶诊断以及监测CXL治疗的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号